Business description: PHAXIAM Therapeutics S.A.

PHAXIAM Therapeutics S.A. is a biopharmaceutical company developing innovative treatments for resistant bacterial infections, responsible for many serious infections. The company relies on an innovative approach based on the use of phages, natural bacteria-killing viruses. PHAXIAM Therapeutics S.A. is developing a portfolio of phages targeting 3 of the most resistant and dangerous bacteria, which alone account for more than two-thirds of resistant nosocomial infections: Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa.

Number of employees: 68

Sales by Activity: PHAXIAM Therapeutics S.A.

Fiscal Period: December20192020202120222023

Research and Development of Innovative Red Blood Cell-Based Therapeutics

5.28M 3.72M 4.18M 6.65M 1.33M
See all business segments

Geographical breakdown of sales: PHAXIAM Therapeutics S.A.

Fiscal Period: December20192020202120222023

France

- - - 60K 235K

United States

- - 128K 134K -
See all geographic segments

Managers: PHAXIAM Therapeutics S.A.

Insiders TitleAgeSince
Director of Finance/CFO 57 23-06-22
Human Resources Officer - 23-06-22
Corporate Officer/Principal 45 23-06-22
See PHAXIAM THERAPEUTICS S.A. governance

Members of the board: PHAXIAM Therapeutics S.A.

Director TitleAgeSince
Chairman 68 23-06-22
Director/Board Member 63 23-06-22
Director/Board Member 76 23-06-22
Composition of the Board of Directors

Shareholders: PHAXIAM Therapeutics S.A.

NameEquities%Valuation
Armistice Capital LLC
1.583 %
176,265 1.583 % 375 934 €
Auriga Partners SA
1.115 %
124,158 1.115 % 264 802 €
RECORDATI
0.4187 %
46,636 0.4187 % 99 464 €
OFI Invest Asset Management SA
0.1640 %
18,270 0.1640 % 38 966 €
BVF Partners LP
0.0946 %
10,532 0.0946 % 22 462 €
NameEquities%Valuation
Asset Dedication LLC
0.000000 %
0 0.000000 % - €
List of PHAXIAM THERAPEUTICS S.A. shareholders

Holdings: PHAXIAM Therapeutics S.A.

NameEquities%Valuation
270 0.00% 576 $

Company details: PHAXIAM Therapeutics S.A.

PHAXIAM Therapeutics SA

60, avenue Rockefeller Bâtiment Bioserra

69008, Lyon

+

http://www.phaxiam.com
address PHAXIAM Therapeutics S.A.(PHXM)

Bio Therapeutic Drugs

Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
-0.30%-1.50%-67.81%-95.30% 21.23M
+0.88%+1.03%+36.82%+152.99% 128B
+0.58%-1.14%+45.62%+82.28% 115B
-0.44%-1.14%-11.05%+59.01% 27.85B
+0.73%+2.17%-20.73%-69.36% 20.77B
+0.86%+3.91%-29.49%-33.12% 17.42B
+4.00%+8.91%-18.52%-49.98% 17.03B
+1.19%+5.31%-40.90%-75.26% 15.37B
-0.28%-1.48%+47.06%+48.05% 14.62B
+0.51%-4.14%+38.24%+111.76% 13.83B
Average +0.77%+1.23%-2.08%+13.11% 37.03B
Weighted average by Cap. +0.77%+0.70%+24.29%+78.15%
See all sector performances
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.954EUR
Average target price
5.100EUR
Spread / Average Target
+161.00%
Consensus

Profit revisions

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. PHXM Stock
  4. Company PHAXIAM Therapeutics S.A.